Sequential injection of rEIII + anti-NS1 Igs or rEIII + anti-CD41 Igs (CD41 is a putative anti-NS1 Ig targets on platelets) (45) significantly exacerbated thrombocytopenia, plasma leakage, and liver damage (Figure S6). This evidence concerns the gene ITGA2B and Thrombocytopenia.